Virologic outcomes in early antiretroviral treatment: HPTN 052
© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early antiretroviral therapy (ART) prevented 93% of HIV transmission events in serodiscordant couples. Some linked infections were observed shortly a...
Saved in:
相似書籍
-
Virologic outcomes in early antiretroviral treatment: HPTN 052
由: Susan H. Eshleman, et al.
出版: (2018) -
Virologic outcomes in early antiretroviral treatment: HPTN 052
由: Eshleman S., et al.
出版: (2017) -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
由: Philip J. Palumbo, et al.
出版: (2018) -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
由: Philip J. Palumbo, et al.
出版: (2018) -
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
由: Philip J. Palumbo, et al.
出版: (2018)